Home > Insider Trading > Filing (0001365618-13-000002)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1411158	Anacor Pharmaceuticals Inc.	ANAC	Pharmaceutical Preparations (2834)	251854385

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1365618	D Anders Hove	C/O Venrock 3340 Hillview Ave. Palo Alto CA 94304		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-11-15	150,000	$14.06	3,575,535	No	4	S	Indirect	By Funds and LLC's

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Funds and LLC's

Footnotes

Consists of 1,652,044 shares held by Venrock Associates IV, L.P. ("VA4"), 336,902 shares held by Venrock Partners, L.P. ("VP"), 40,590 shares held by Venrock Entrepreneurs Fund IV, L.P. ("VEF4"), 1,306,927 shares held by Venrock Healthcare Capital Partners, L.P. ("VHCP") and 239,072 shares held by VHCP Co-Investment Holdings LLC ("VHCP Co-Invest").
Venrock Management IV, LLC ("VM4"), Venrock Partners Management, LLC ("VPM") and VEF Management IV, LLC ("VEFM4") are the sole general partners of VA4, VP and VEF4, respectively, and may be deemed to beneficially own these shares. VHCP Management, LLC is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. Anders Hove is a member of VM4, VPM, VEFM4, and a managing member of VHCP Management. Dr. Hove expressly disclaims beneficial ownership over all shares held by VA4, VP, VEF4, VHCP, VHCP Co-Invest, VM4, VPM, VEFM4, and VHCP Management except to the extent of his indirect pecuniary interest therein.